.png?x-oss-process=image/resize,p_100/format,webp)
Typically, short-chain fatty acids (SCFAs), including propionate and butyrate, hinder the expression of adhesion molecules triggered by stimuli and decrease chemokine synthesis, thereby impeding the mobilization of monocytes/macrophages and neutrophils. This indicates a potential anti-inflammatory effect.
The onset and persistence of adipose tissue inflammation are driven by malfunctioning adipocytes which release inflammatory adipokines, coupled with the infiltration of immune cells originating from the bone marrow that communicate through the generation of cytokines and chemokines.
A research paper, released on Thursday in Circulation Research, a publication of the American Heart Association, uncovered that fish oil capsules with a particular blend of omega-3 fatty acids decreased inflammation by boosting the levels of specific "mediator" molecules that control the functions of certain blood components.
Acetic acid, propionic acid, and butyric acid constitute the trio of the most prevalent SCFAs. Notably, butyric acid holds significant importance for the wellbeing of the colon, serving as the prime energetic resource for colonocytes, which are the epithelial lining cells of the colon.
Consumption of an abundant amount of foods high in fiber, including fruits, vegetables, and beans, has been associated with an elevation in short-chain fatty acids (9). A research study with 153 participants observed favorable correlations between a greater consumption of plant-based foods and elevated concentrations of short-chain fatty acids in feces (10).
Short-chain fatty acids exert a diverse array of influences on the brain of the host. They impact the integrity of the blood-brain barrier, modulate the typical growth and operations of microglia, engage in inflammatory processes, and even modify the concentrations of neurotransmitters and intracellular potassium. 15th April, 2022
The small intestine is the exclusive site of expression for Intestinal fatty acid-binding protein, alternatively known as FABP2 or I-FABP. This protein facilitates the transportation of lipids from the intestinal lumen into enterocytes and binds excess fatty acids, thereby ensuring a constant supply of fatty acids within the epithelial layer.
Although SCFAs exert a notable beneficial influence on the intestinal milieu by lowering colonic pH levels [96] and adjusting microbial balance and colonic energy equilibrium [74,97], they also mitigate obesity-associated inflammation [98] and govern glucose metabolism [99] as well as lipid regulation [100] (depicted in Figure 2).
Short-chain fatty acids enhance gut well-being via various localized mechanisms, encompassing the preservation of intestinal barrier cohesion, the generation of mucus, safeguarding against inflammatory responses, and diminishing the likelihood of colorectal cancer occurrence (78–81). 30th January 2020
Certain fatty acids, which are not as common, exhibit an impact on LDL cholesterol levels. Specifically, when consumed in amounts equivalent to saturated fatty acids, trans-monounsaturated fatty acids increase LDL cholesterol. Conversely, polyunsaturated fatty acids, taken at a dosage three times that of saturated fatty acids, serve to decrease LDL cholesterol.